vs

Side-by-side financial comparison of Civeo Corp (CVEO) and Inspire Medical Systems, Inc. (INSP). Click either name above to swap in a different company.

Inspire Medical Systems, Inc. is the larger business by last-quarter revenue ($269.1M vs $161.6M, roughly 1.7× Civeo Corp). Inspire Medical Systems, Inc. runs the higher net margin — 50.6% vs -4.0%, a 54.6% gap on every dollar of revenue. On growth, Inspire Medical Systems, Inc. posted the faster year-over-year revenue change (12.2% vs 7.1%). Inspire Medical Systems, Inc. produced more free cash flow last quarter ($41.8M vs $14.5M). Over the past eight quarters, Inspire Medical Systems, Inc.'s revenue compounded faster (28.1% CAGR vs -1.4%).

The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

CVEO vs INSP — Head-to-Head

Bigger by revenue
INSP
INSP
1.7× larger
INSP
$269.1M
$161.6M
CVEO
Growing faster (revenue YoY)
INSP
INSP
+5.2% gap
INSP
12.2%
7.1%
CVEO
Higher net margin
INSP
INSP
54.6% more per $
INSP
50.6%
-4.0%
CVEO
More free cash flow
INSP
INSP
$27.4M more FCF
INSP
$41.8M
$14.5M
CVEO
Faster 2-yr revenue CAGR
INSP
INSP
Annualised
INSP
28.1%
-1.4%
CVEO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVEO
CVEO
INSP
INSP
Revenue
$161.6M
$269.1M
Net Profit
$-6.5M
$136.1M
Gross Margin
22.7%
86.6%
Operating Margin
-0.1%
17.1%
Net Margin
-4.0%
50.6%
Revenue YoY
7.1%
12.2%
Net Profit YoY
58.1%
286.4%
EPS (diluted)
$-0.58
$4.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVEO
CVEO
INSP
INSP
Q4 25
$161.6M
$269.1M
Q3 25
$170.5M
$224.5M
Q2 25
$162.7M
$217.1M
Q1 25
$144.0M
$201.3M
Q4 24
$151.0M
$239.7M
Q3 24
$176.3M
$203.2M
Q2 24
$188.7M
$195.9M
Q1 24
$166.1M
$164.0M
Net Profit
CVEO
CVEO
INSP
INSP
Q4 25
$-6.5M
$136.1M
Q3 25
$-455.0K
$9.9M
Q2 25
$-3.3M
$-3.6M
Q1 25
$-9.8M
$3.0M
Q4 24
$-15.4M
$35.2M
Q3 24
$-5.1M
$18.5M
Q2 24
$8.2M
$9.8M
Q1 24
$-5.1M
$-10.0M
Gross Margin
CVEO
CVEO
INSP
INSP
Q4 25
22.7%
86.6%
Q3 25
25.7%
85.8%
Q2 25
25.3%
84.0%
Q1 25
20.4%
84.7%
Q4 24
18.6%
85.0%
Q3 24
21.4%
84.1%
Q2 24
25.4%
84.8%
Q1 24
21.5%
84.9%
Operating Margin
CVEO
CVEO
INSP
INSP
Q4 25
-0.1%
17.1%
Q3 25
4.1%
4.3%
Q2 25
1.7%
-1.5%
Q1 25
-3.8%
-0.7%
Q4 24
-6.7%
13.3%
Q3 24
0.0%
7.0%
Q2 24
6.9%
2.6%
Q1 24
-1.1%
-9.3%
Net Margin
CVEO
CVEO
INSP
INSP
Q4 25
-4.0%
50.6%
Q3 25
-0.3%
4.4%
Q2 25
-2.0%
-1.7%
Q1 25
-6.8%
1.5%
Q4 24
-10.2%
14.7%
Q3 24
-2.9%
9.1%
Q2 24
4.4%
5.0%
Q1 24
-3.1%
-6.1%
EPS (diluted)
CVEO
CVEO
INSP
INSP
Q4 25
$-0.58
$4.57
Q3 25
$-0.04
$0.34
Q2 25
$-0.25
$-0.12
Q1 25
$-0.72
$0.10
Q4 24
$-1.04
$1.17
Q3 24
$-0.36
$0.60
Q2 24
$0.56
$0.32
Q1 24
$-0.35
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVEO
CVEO
INSP
INSP
Cash + ST InvestmentsLiquidity on hand
$14.4M
$308.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$174.4M
$781.2M
Total Assets
$477.4M
$907.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVEO
CVEO
INSP
INSP
Q4 25
$14.4M
$308.3M
Q3 25
$12.0M
$322.6M
Q2 25
$14.6M
$300.9M
Q1 25
$28.4M
$369.2M
Q4 24
$5.2M
$445.5M
Q3 24
$17.9M
$411.0M
Q2 24
$7.4M
$439.7M
Q1 24
$16.8M
$441.4M
Total Debt
CVEO
CVEO
INSP
INSP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$43.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CVEO
CVEO
INSP
INSP
Q4 25
$174.4M
$781.2M
Q3 25
$182.5M
$666.5M
Q2 25
$209.4M
$677.8M
Q1 25
$220.7M
$635.7M
Q4 24
$236.4M
$689.7M
Q3 24
$282.2M
$696.6M
Q2 24
$297.4M
$638.1M
Q1 24
$297.4M
$589.0M
Total Assets
CVEO
CVEO
INSP
INSP
Q4 25
$477.4M
$907.3M
Q3 25
$491.1M
$807.7M
Q2 25
$508.8M
$802.2M
Q1 25
$423.8M
$730.8M
Q4 24
$405.1M
$808.4M
Q3 24
$477.6M
$796.2M
Q2 24
$483.2M
$728.4M
Q1 24
$513.1M
$685.8M
Debt / Equity
CVEO
CVEO
INSP
INSP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.18×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVEO
CVEO
INSP
INSP
Operating Cash FlowLast quarter
$19.3M
$52.5M
Free Cash FlowOCF − Capex
$14.5M
$41.8M
FCF MarginFCF / Revenue
8.9%
15.5%
Capex IntensityCapex / Revenue
3.0%
4.0%
Cash ConversionOCF / Net Profit
0.39×
TTM Free Cash FlowTrailing 4 quarters
$2.1M
$78.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVEO
CVEO
INSP
INSP
Q4 25
$19.3M
$52.5M
Q3 25
$13.8M
$68.5M
Q2 25
$-2.3M
$2.7M
Q1 25
$-8.4M
$-6.7M
Q4 24
$9.5M
$69.2M
Q3 24
$35.7M
$52.3M
Q2 24
$32.4M
$-78.0K
Q1 24
$6.0M
$8.9M
Free Cash Flow
CVEO
CVEO
INSP
INSP
Q4 25
$14.5M
$41.8M
Q3 25
$8.2M
$58.1M
Q2 25
$-6.8M
$-6.3M
Q1 25
$-13.7M
$-15.1M
Q4 24
$1.8M
$62.2M
Q3 24
$28.2M
$44.3M
Q2 24
$27.0M
$-12.5M
Q1 24
$372.0K
$-2.8M
FCF Margin
CVEO
CVEO
INSP
INSP
Q4 25
8.9%
15.5%
Q3 25
4.8%
25.9%
Q2 25
-4.2%
-2.9%
Q1 25
-9.5%
-7.5%
Q4 24
1.2%
25.9%
Q3 24
16.0%
21.8%
Q2 24
14.3%
-6.4%
Q1 24
0.2%
-1.7%
Capex Intensity
CVEO
CVEO
INSP
INSP
Q4 25
3.0%
4.0%
Q3 25
3.3%
4.6%
Q2 25
2.8%
4.1%
Q1 25
3.7%
4.2%
Q4 24
5.1%
2.9%
Q3 24
4.2%
3.9%
Q2 24
2.8%
6.3%
Q1 24
3.4%
7.1%
Cash Conversion
CVEO
CVEO
INSP
INSP
Q4 25
0.39×
Q3 25
6.90×
Q2 25
Q1 25
-2.24×
Q4 24
1.96×
Q3 24
2.83×
Q2 24
3.93×
-0.01×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons